Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EU CHMP Opinions And MAA Updates

Jul 30 2024

• By Neena Brizmohun

EU CHMP Opinions and MAA Updates — • Source: Pink Sheet/Shutterstock

Related Content

Lilly Pulls EU Approval Application For Olumiant In COVID-19

Dec 19 2022

Hemophilia B Gene Therapy Among Five Drugs On Track For EU-Wide Approval

Dec 16 2022

ERC Not Giving Up On Glioma Immunotherapy In EU

May 23 2022

PTC’s ‘Life-Changing’ Gene Therapy Among Nine Drugs To Win EU Thumbs Up

May 20 2022

Kite Wins EMA Recommendation To Market Tecartus For Leukemia Patients

Jul 25 2022

Janssen’s Multiple Myeloma Drug Among 11 Products To Get EMA Thumbs Up

Jul 22 2022

Sanofi & GSK Win COVID-19 Vaccine Approval In EU Using Immunobridging Trials

Nov 11 2022

EU Filing For Infigratinib Pulled After Commercial Deal Crumbles

Nov 07 2022

Dengue Vaccine Qdenga & Nine Drugs Win EMA Thumbs Up

Oct 17 2022

Marketing Firsts Due As Amryt’s Filsuvez And Roche’s Lunsumio Win EU Nod

Apr 25 2022

Biogen Pulls EU Filing For Aduhelm But Stands By Alzheimer’s Drug

Apr 22 2022

EMA Gives Oncopeptides’ Multiple Myeloma Drug The Thumbs Up; Keeps US FDA In Loop

Jun 24 2022

BioMarin’s Hemophilia Gene Therapy Among Nine Products On Track For EU-Wide Approval

Jun 24 2022

Valneva Wins EU Nod For COVID-19 Vaccine

Jun 23 2022

BMS’ Cell Therapy For Lymphoma On Track For EU-Wide Approval

Jan 28 2022

Ophthalmic Bevacizumab Sponsor Not Giving Up On EMA Rejection

Jan 28 2022

EMA OKs First Drug To Prevent RSV Infection In Babies

Sep 16 2022

EMA ‘Extremely Collaborative And Well Prepared’ During Review Of Santhera’s DMD Drug Agamree

Oct 16 2023

EMA Backs Approval Of Santhera’s Agamree, Pfizer’s Elrexfio & Several Other New Drugs

Oct 13 2023

Bad News For Amylyx As EMA Upholds Rejection Of ALS Drug Albrioza

Oct 13 2023

Mirati To Challenge EMA’s Rejection Of US-Approved Krazati

Jul 21 2023

EMA Says Yes To Janssen’s Talvey & 13 Other Drugs

Jul 21 2023

EMA Says Yes To BMS’ Sotyktu But Turns Down Ipsen’s Sohonos

Jan 27 2023

EMA Thumbs Up For HyQvia As Maintenance Therapy For Rare Neurological Disorder

Dec 18 2023

EMA OKs Seven New Drugs Including First RSV Vaccine For Older Adults

Apr 27 2023

Lilly’s Omvoh Among Nine New Drugs Securing EU Marketing Thumbs Up

Mar 31 2023

AbbVie’s Aquipta & GSK’s Jesduvroq Move Closer To EU Market

Jun 23 2023

Amylyx To Appeal Against EMA Rejection Of ALS Drug Albrioza

Jun 23 2023

EMA Says Yes To GSK’s Omjjara, UCB’s Rystiggo and Novartis’ Spexotras

Nov 10 2023

Success For Mirati As EMA Backs Krazati For EU Approval After Initial Rejection

Nov 13 2023

EMA Backs Approval For Eight New Drugs But Rejects Lagevrio For COVID-19

Feb 24 2023

First Gene Editing Therapy Among Seven Drugs On Track For EU-Wide Approval

Dec 15 2023

AstraZeneca/Daiichi Sankyo’s Enhertu To Get Lung Cancer Label For EU

Sep 18 2023

SK Bioscience Pulls EU Filing For COVID Jab As Regulators Shift Focus To XBB Vaccines

Sep 15 2023

Lebrikizumab Among Nine Drugs To Get EMA Nod; PTC Faces Disappointment For Translarna

Sep 15 2023

Outlook Turns To Marketing Strategy After Scoring EU First For Ophthalmic Bevacizumab

Mar 22 2024

EMA Says Yes To 12 New Drugs Including Pfizer/AbbVie’s Antibiotic Combo

Mar 22 2024

EMA Thumbs Up For Idorsia’s Insomnia Drug And Immunocore’s Uveal Melanoma Treatment

Feb 25 2022

Chikungunya Vaccine, Hemophilia B Gene Therapy Among 14 Products On Track For EU Approval

May 31 2024

Janssen’s Multiple Myeloma Gene Therapy On Track For EU-Wide Approval

Mar 25 2022

Two Avian Flu Vaccines Among 10 New Products To Get EMA Nod

Feb 23 2024

Idorsia’s Novel Hypertension Pill Among Eight New Drugs To Win EMA Nod

Apr 26 2024

First Nasal Adrenaline Spray Among 10 Products Heading For EU-Wide Approval

Jun 28 2024

EMA Turns Down Minoryx’s Orphan Drug Nezglyal & Apellis’ Syfovre, OKs Three Others

Jan 26 2024

EMA Considers Cardiovascular Indication & Extra Market Protection For Wegovy

Jan 23 2024

EU Blow For Alzheimer’s Drug Leqembi; Eisai To Appeal

Jul 26 2024

New Drugs For Gastric Cancer, Liver Disease Among 14 Products Heading For EU Approval

Jul 26 2024

Additional Topics

Europe Drug Review Regulation Approvals Review Pathway European Performance Tracker BioPharmaceutical

More from European Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window